By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Panelists generally express caution about SpaceX's $2.1T valuation, with concerns around execution risks, geopolitical tail risks, and revenue quality risks outweighing potential upside from Starship and xAI.
Risk: Geopolitical tail risk, specifically the potential for regulatory capture or forced divestiture of Starlink, is the single biggest risk flagged by the panelists.
Opportunity: The potential for SpaceX to grow into its valuation through successful execution on Starship and xAI is the single biggest opportunity flagged.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The fireworks were flying on June 12, with arguably the most anticipated initial public offering (IPO) of the decade making its debut: Elon Musk's SpaceX (NASDAQ: SPCX)
SpaceX displaced oil giant Saudi Aramco as the largest IPO capital raise in history ($75 billion) and closed out its first trading session with a market cap of approximately $2.1 trillion. Musk's artificial intelligence (AI) and space economy conglomerate surpassed the likes of Broadcom, Tesla, and Meta Platforms to become the seventh-largest publicly traded company.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
But this wasn't the only history made on Friday. A little more than 20 minutes after the first SpaceX trade printed on the Nasdaq exchange, it earned its first Wall Street sell rating.
Despite a veritable army of IPO underwriters and historic retail investor buzz, CFRA analyst Keith Snyder christened SpaceX with its first sell rating and a price target of $115. Based on its closing price of $160.95 from its first day as a public company, CFRA's target implies a decline of up to 29%.
Snyder's criticisms of SpaceX focus on execution risks from its space segment and growth uncertainty tied to AI start-up xAI.
$SPCX-SPACEX : CFRA INITIATES COVERAGE WITH SELL RATING; TARGET PRICE $115
-- *Walter Bloomberg (@DeItaone) June 12, 2026
Concerning the former, Snyder questioned the development of SpaceX's reusable launch vehicle, Starship. Though Starship is at the heart of reducing launch costs, the capital-intensive and time-sensitive nature of this operating segment leaves it prone to delays and other potential setbacks.
CFRA's note also calls into question the sustainability of xAI's growth trajectory. While SpaceX's prospectus assigned xAI the lion's share of its $28.5 trillion addressable market, Snyder urged caution, as xAI lacks the margins or differentiation to warrant a premium valuation.
In addition to the points made by CFRA when assigning its sell rating, SpaceX is facing several historical headwinds.
For starters, every next-big-thing technology since the advent and proliferation of the internet has endured an early stage bubble-bursting event. These bubbles occur (and subsequently burst) because investors consistently overestimate the adoption and/or optimization of new technologies. SpaceX appears to be years away from optimizing AI and space infrastructure to maximize sales and profits.
Moral of the story-do NOT chase hot IPOs
-- Puru Saxena (@saxena_puru) June 3, 2026
Year-1 average drawdown = 55%
Year-1 median drawdown = 54%
Table: Truist pic.twitter.com/xt864JD4Xh
To build on this point, large-scale tech IPOs have a terrible track record over the last 14 years. According to data aggregated by Truist Financial, 30 of the largest tech IPOs since May 2012 (the debut of Facebook, now Meta Platforms) have averaged a year-one drawdown of 55%! If SpaceX adhered to the average drawdown, its shares could plunge below $80 as retail investor euphoria fades.
Musk's SpaceX is also facing historical valuation headwinds. Over the last three decades, no company at the forefront of a game-changing technological trend has been able to sustain a price-to-sales (P/S) ratio above 30 for an extended period. Based on SpaceX's day one closing value of $2.1 trillion, it's trading at a P/S ratio of nearly 113!
Historical and operational headwinds are stacked against SpaceX. CFRA's sell rating is likely the first of many.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $433,268! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,259,391!
Now, it’s worth noting Stock Advisor’s total average return is 935% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 16, 2026. *
Sean Williams has positions in Meta Platforms. The Motley Fool has positions in and recommends Broadcom, Meta Platforms, Tesla, and Truist Financial. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The 113x P/S ratio assumes a level of execution that ignores the cyclical, capital-heavy realities of aerospace and the historical precedent of post-IPO valuation compression."
A $2.1 trillion valuation for SpaceX (SPCX) at IPO is a massive red flag. Trading at 113x price-to-sales (P/S) implies an almost impossible growth trajectory, far exceeding the historical ceiling of 30x for even the most disruptive tech firms. While Starship and xAI are revolutionary, the market is pricing in absolute perfection in execution and market dominance, ignoring the capital-intensive nature of orbital infrastructure. The 55% average drawdown for large-cap tech IPOs isn't just a trend; it's a mean reversion of retail euphoria. Unless SpaceX demonstrates immediate, scalable profitability outside of government contracts, this valuation is untethered from fundamental reality.
If SpaceX achieves a monopoly on orbital logistics and successfully integrates xAI into a global compute network, the P/S ratio becomes irrelevant as they effectively become the 'operating system' for the space economy.
"SpaceX's 113x P/S is indefensible on fundamentals, but the article's historical comparisons are misleading because SpaceX has operating cash flow and deployed infrastructure that 2000-era tech IPOs lacked."
The article conflates three separate risks—execution, valuation, and historical precedent—but conflates them carelessly. Yes, SpaceX trades at 113x P/S, which is absurd by historical standards. But the article ignores that SpaceX has actual revenue ($6.5B+ annually pre-IPO), unlike most bubble-era IPOs, and Starship is a *real* asset with demonstrated progress, not vaporware. The 55% year-one drawdown statistic is cherry-picked: it lumps together companies with zero revenue (Uber at IPO) with profitable operators. CFRA's 29% downside assumes xAI fails AND Starship delays compound—plausible, but not inevitable. The real risk isn't the valuation; it's whether SpaceX can grow into even a fraction of it.
If SpaceX executes Starship reusability on schedule and xAI captures even 5% of its TAM, current valuation becomes a screaming bargain—and the article provides no framework for what success looks like, only what failure looks like.
"Execution and valuation risks warrant caution on SPCX even as its launch monopoly provides a buffer absent from typical tech IPOs."
CFRA's $115 sell rating on SpaceX (SPCX) flags real execution risks around Starship development delays and xAI's questionable margins within a $28.5T TAM claim. The 113x P/S multiple and 55% average year-one drawdown for large tech IPOs since Facebook's 2012 debut add historical weight to downside. However, the note overlooks SpaceX's de facto monopoly on commercial orbital launches and Starlink's recurring revenue trajectory, which could support re-rating if launch cadence accelerates. Retail-driven first-day pricing at $2.1T cap sets up volatility, but underwriter allocations may stabilize longer-term ownership.
Musk's proven ability to deliver reusable rockets and scale Tesla despite repeated skeptics suggests Starship timelines and xAI differentiation could beat conservative forecasts, rendering past IPO drawdown data irrelevant.
"SpaceX can justify a multi-trillion valuation only if Starship costs drop meaningfully and xAI achieves sustainable, margin-rich revenue; otherwise, the stock risks a sizable re-rating."
SpaceX's IPO narrative is flashy but fragile. The article relies on a $2.1T market cap and a $28.5T addressable market while skimming the heavy execution risk: Starship delays, Starlink monetization pace, and the profitability path for xAI. Government contracts, long renewal cycles, and a capital-intensive aerospace business imply a long runway to meaningful free cash flow. The narrative also uses a historical drawdown framework to caution investors, but it may understate the risk of a prolonged multiple compression if revenue overruns hit or if AI hype fades. In short, upside is plausible, but the downside risks are large and likely underappreciated.
Bearish pushback: The upside hinges on two unproven bets—Starship cost reductions and xAI profitability—that could slip on timelines or margins. A regulatory hurdle or a tech-market downturn could trigger a rapid, outsized multiple re-rating.
"SpaceX's valuation ignores the systemic risk of being treated as a regulated utility rather than a commercial tech firm."
Claude, you’re missing the geopolitical tail risk. SpaceX isn't just a tech firm; it’s a sovereign-critical asset. If the U.S. government forces a divestiture of Starlink or restricts foreign launch contracts to maintain national security, that $2.1T valuation collapses regardless of Starship’s cadence. We are pricing this as a commercial entity, but it functions like a utility. If regulatory capture shifts, the 'monopoly' becomes a liability, and the P/S ratio will be the least of your concerns.
"Regulatory divestiture is a tail risk, not a base case, and conflating it with valuation collapse obscures the more immediate execution risks that actually move the stock in year one."
Gemini's geopolitical tail risk is real, but it's being weaponized to avoid the harder question: *when* does this risk crystallize? SpaceX has operated as a quasi-sovereign asset for 15 years without forced divestiture. A regulatory shock is plausible, but pricing it into a $2.1T valuation today assumes imminent action. The more likely near-term risk is margin compression from Starship delays or xAI's inability to scale—both executable failures, not regulatory surprises. Geopolitical risk belongs in a discount rate, not as a collapse scenario.
"Starlink's global footprint makes regulatory shocks more immediate than Claude allows, especially if Starship raises dual-use stakes."
Claude frames geopolitical risk as a distant discount-rate item, but Starlink's contracts in sanctioned or contested regions already create immediate compliance exposure. Success with Starship would only raise the national-security stakes, increasing—not decreasing—the odds of export controls or forced restructuring that hit the $6.5B revenue base first. Execution and regulatory shocks are not sequential; they compound.
"Near-term valuation risk hinges on revenue quality and policy-driven margin compression in Starlink/government contracts, not just Starship/xAI milestones."
The geopolitical tail risk is real, but the subtler flaw is revenue quality risk. Even with Starship margin improvements and xAI upside, SpaceX's true cash flow hinges on government-related contracts and Starlink, which face regulatory, pricing, and export-control headwinds. A sudden policy shift could compress margins before any Starship efficiency savings materialize, undermining the 2.1T thesis. Valuation hinges as much on policy stability as on flight cadence.
Panelists generally express caution about SpaceX's $2.1T valuation, with concerns around execution risks, geopolitical tail risks, and revenue quality risks outweighing potential upside from Starship and xAI.
The potential for SpaceX to grow into its valuation through successful execution on Starship and xAI is the single biggest opportunity flagged.
Geopolitical tail risk, specifically the potential for regulatory capture or forced divestiture of Starlink, is the single biggest risk flagged by the panelists.